- Home
- GHY vs INNV Comparison
GHY vs INNV Comparison
Compare GHY & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHY
- INNV
- Stock Information
- Founded
- GHY 2012
- INNV 2007
- Country
- GHY United States
- INNV United States
- Employees
- GHY N/A
- INNV N/A
- Industry
- GHY Trusts Except Educational Religious and Charitable
- INNV Medical/Nursing Services
- Sector
- GHY Finance
- INNV Health Care
- Exchange
- GHY Nasdaq
- INNV Nasdaq
- Market Cap
- GHY 548.8M
- INNV 485.4M
- IPO Year
- GHY N/A
- INNV 2021
- Fundamental
- Price
- GHY $13.23
- INNV $4.40
- Analyst Decision
- GHY
- INNV Sell
- Analyst Count
- GHY 0
- INNV 2
- Target Price
- GHY N/A
- INNV $5.00
- AVG Volume (30 Days)
- GHY 184.8K
- INNV 25.5K
- Earning Date
- GHY 01-01-0001
- INNV 09-09-2025
- Dividend Yield
- GHY 10.58%
- INNV N/A
- EPS Growth
- GHY N/A
- INNV N/A
- EPS
- GHY N/A
- INNV N/A
- Revenue
- GHY N/A
- INNV $853,699,000.00
- Revenue This Year
- GHY N/A
- INNV $12.10
- Revenue Next Year
- GHY N/A
- INNV $11.49
- P/E Ratio
- GHY N/A
- INNV N/A
- Revenue Growth
- GHY N/A
- INNV 11.76
- 52 Week Low
- GHY $10.24
- INNV $2.60
- 52 Week High
- GHY $11.92
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- GHY 44.45
- INNV 60.89
- Support Level
- GHY $13.31
- INNV $3.69
- Resistance Level
- GHY $13.43
- INNV $4.63
- Average True Range (ATR)
- GHY 0.10
- INNV 0.31
- MACD
- GHY -0.01
- INNV 0.08
- Stochastic Oscillator
- GHY 13.88
- INNV 74.41
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.